NNIT FB23 Topbanner #4

Get inspiration on data enablement, digitalization and new agendas

Would you like to know more about how your organization can work with data enablement, digital business models and processes, and new agendas? Five NNIT experts share their best tips.  

For companies in the life sciences industry, data is a crucial asset to create better results throughout the value chain – from clinical trials to product launch and gathering data from the market. Yet many organizations are still not realizing their full data potential.

In this article series, the NNIT experts share their concrete experience and advice for how to leverage data in different aspects of the life sciences industry.

Here’s a summary of each article:

Global cooperation between health authorities and increased focus on structured data reporting are just some of the regulatory trends impacting pharma companies. Christopher Lucas, Consulting Director US Research & development at NNIT Inc., explains how digital solutions can enhance regulatory data.

Read the article here

Reports of adverse events are increasing rapidly, placing a heavy burden on pharmacovigilance teams in the life sciences industry. Jesper Borgstrøm, Senior Business Consultant at NNIT, explains how advanced digital tools can help you process the growing influx of safety data to provide clarity and extract more value.

Read the article here

Both sponsors and research sites can benefit by increasing the use of digitalization and data enablement in clinical trials. According to Martin Lim, Managing Consultant at NNIT, streamlined patient recruitment, better data capture and reduced investigator burnout are just some of the advantages.

Read the article here

By analyzing their quality data, pharma companies can find the weak points in their value chain and optimize their processes. Charlotte Øbakke, Head of Quality, Europe at NNIT explains how digital tools and strong data models and be used to improve quality across your business.

Read the article her.

How much of the process-related data generated by your pharma production provides real value? According to Marco Glauner, Head of Manufacturing & Supply Chain Solutions Europe at NNIT, a fresh look at existing manufacturing, laboratory and serialization data can reveal multiple opportunities for improving your business. 

Read the article here.

Want to learn more about the topic?

Read the article "Data enablement is the key to staying relevant and competitive in the life sciences industry" and learn more about the topic and why Data Enablement is the theme of NNIT Expectation Barometer here.

About NNIT Expectation Barometer  

Every year, NNIT conducts an Expectation Barometer. It is an online survey where we focus on digitalization and take the pulse of different digital themes in organizations, spiced with in-depth interviews and case stories with selected digital leaders.  

This time the focus has been on data enablement and the enormous potential of utilizing data across the life sciences industry to improve quality and competitiveness – and ultimately bring better products to patients.